预防性氯胺酮:当前知识与未来方向
本综述概述了氯胺酮作为应激所致障碍(包括抑郁、焦虑、创伤后应激障碍和产后抑郁)预防性用药的临床前与临床证据,涉及(R,S)-氯胺酮及(2R,6R)-和(2S,6S)-羟基去甲氯胺酮,并探讨了脑区/环路及谷氨酸能、多巴胺能、5-羟色胺能和炎症等潜在机制,同时强调了年龄和性别特异性疗效、长期不良反应及法律伦理等局限与风险,最后讨论了未来研究方向。
要点
- 氯胺酮作为应激所致障碍预防性用药的证据来自临床前与临床研究。
- 涉及(R,S)-氯胺酮及(2R,6R)-和(2S,6S)-羟基去甲氯胺酮的预防作用。
- 需关注年龄和性别特异性疗效、长期不良反应及法律伦理问题。
核心结论
- 文献强调需继续研究以更好理解氯胺酮作为应激所致障碍预防性用药的潜在获益与风险。
研究设计与样本
- 本综述概述了氯胺酮作为应激所致障碍预防性用药的当前知识,包括(R,S)-氯胺酮及(2R,6R)-和(2S,6S)-羟基去甲氯胺酮的临床前与临床发现。
主要发现
- 综述探讨了预防这些障碍的潜在机制,包括脑区/环路及谷氨酸能、多巴胺能、5-羟色胺能和炎症过程。
- 综述强调了氯胺酮使用的局限与风险,如年龄和性别特异性疗效、潜在长期不良反应及法律伦理考量。
局限性
- 氯胺酮使用存在年龄和性别特异性疗效的局限。
- 氯胺酮使用存在潜在长期不良反应的风险。
- 氯胺酮使用涉及法律和伦理考量。
- 文献强调需继续研究以更好理解氯胺酮作为预防性用药的潜在获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The prevalence of stress-induced disorders, including depression, anxiety, posttraumatic stress disorder, and postpartum depression, has been increasing, while current treatment approaches are limited. As a result, researchers are exploring alternative treatments that include ketamine as a prophylactic against these disorders. This review provides an overview of the current knowledge on the use of ketamine as a prophylactic for stress-induced disorders, including preclinical and clinical findings on (R,S)-ketamine, as well as (2R,6R)- and (2S,6S)-hydroxynorketamine. We also explore the potential underlying mechanisms involved in preventing these disorders, including the brain regions/circuits, as well as glutamatergic, dopaminergic, serotonergic, and inflammatory processes known to be involved, as evidenced by studies with ketamine and its metabolites. Additionally, we highlight the limitations and risks associated with ketamine use, such as age- and sex-specific efficacy, potential long-term and adverse effects, and legal and ethical considerations. Finally, we discuss future research directions, including the implications for clinical practice, integrating ketamine into current treatment approaches, and potential advancements in ketamine-based therapies. Overall, the literature emphasizes the importance of continuing research to better understand the potential benefits and risks of ketamine as a prophylactic for stress-induced disorders.
引用
- Cardona-Acosta AM, Parise LF, Bolaños-Guzmán CA, et al. Prophylactic Ketamine: Current Knowledge and Future Directions. Biol Psychiatry. 2025. PMID: 40158609. doi:10.1016/j.biopsych.2025.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。